AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection ...
PRESS RELEASE AB SCIENCE ANNOUNCES ISSUANCE OF A EUROPEAN PATENT FOR MASITINIB IN THE TREATMENT OF SEVERE MASTOCYTOSIS WITH PROTECTION UNTIL 2036 Paris, May 13, 2024, 6pm CET AB Science SA (Euronext - FR0010557264 - AB) today announced that the European …